Review





Similar Products

cd101 powder  (Cidara Therapeutics)
90
Cidara Therapeutics cd101 powder
Cd101 Powder, supplied by Cidara Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd101+powder/rezafungin+cd101/10__1128_slash_aac__01750___17-74-0-6
Average 90 stars, based on 1 article reviews
cd101 powder - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
drug powders of cd101  (Cidara Therapeutics)
90
Cidara Therapeutics drug powders of cd101
Drug Powders Of Cd101, supplied by Cidara Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd101+powder/rezafungin+cd101/10__1128_slash_aac__01009___17-216-27-19
Average 90 stars, based on 1 article reviews
drug powders of cd101 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
reference powder of cd101  (Seachaid Pharmaceuticals)
90
Seachaid Pharmaceuticals reference powder of cd101
In vitro susceptibilities of 173 Candida and Aspergillus spp. to <t> CD101, </t> anidulafungin and caspofungin as determined by the CLSI BMD method a
Reference Powder Of Cd101, supplied by Seachaid Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd101+powder/reference+powder+of+cd101/pmc05031917-105-7-11
Average 90 stars, based on 1 article reviews
reference powder of cd101 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


In vitro susceptibilities of 173 Candida and Aspergillus spp. to CD101, anidulafungin and caspofungin as determined by the CLSI BMD method a

Journal: Journal of Antimicrobial Chemotherapy

Article Title: Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

doi: 10.1093/jac/dkw214

Figure Lengend Snippet: In vitro susceptibilities of 173 Candida and Aspergillus spp. to CD101, anidulafungin and caspofungin as determined by the CLSI BMD method a

Article Snippet: – , , The reference powder of CD101 was obtained from Seachaid Pharmaceuticals (Durham, NC, USA).

Techniques: In Vitro

In vitro susceptibilities of Candida and Aspergillus spp. to CD101 as determined by 24 h CLSI and EUCAST BMD methods using prominent (≥50%) MIC endpoint criteria

Journal: Journal of Antimicrobial Chemotherapy

Article Title: Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

doi: 10.1093/jac/dkw214

Figure Lengend Snippet: In vitro susceptibilities of Candida and Aspergillus spp. to CD101 as determined by 24 h CLSI and EUCAST BMD methods using prominent (≥50%) MIC endpoint criteria

Article Snippet: – , , The reference powder of CD101 was obtained from Seachaid Pharmaceuticals (Durham, NC, USA).

Techniques: In Vitro

MICs of CD101, caspofungin and anidulafungin for Candida spp. strains possessing fks hotspot mutations leading to amino-acid alterations

Journal: Journal of Antimicrobial Chemotherapy

Article Title: Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

doi: 10.1093/jac/dkw214

Figure Lengend Snippet: MICs of CD101, caspofungin and anidulafungin for Candida spp. strains possessing fks hotspot mutations leading to amino-acid alterations

Article Snippet: – , , The reference powder of CD101 was obtained from Seachaid Pharmaceuticals (Durham, NC, USA).

Techniques: